Income Taxes (Tables)
|
9 Months Ended |
Jun. 30, 2019 |
Income Taxes [Abstract] |
|
Reconciliation Of Income Tax Expense (Benefit) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
June 30,
|
|
June 30,
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefit at statutory rates
|
$
|
(582,652)
|
|
$
|
(1,412,119)
|
|
$
|
(1,856,337)
|
|
$
|
(5,040,855)
|
State income tax benefit, net of federal benefits
|
|
(138,089)
|
|
|
(15,213)
|
|
|
(439,952)
|
|
|
(963,608)
|
Effect of change in U.S. tax rate
|
|
—
|
|
|
190,319
|
|
|
—
|
|
|
3,319
|
Non-deductible expenses – other
|
|
2,269
|
|
|
862
|
|
|
7,052
|
|
|
13,564
|
Effect of lower foreign income tax rates
|
|
43
|
|
|
(67,765)
|
|
|
(3,484)
|
|
|
12,621
|
Recharacterization of foreign tax credits to net operating loss
|
|
—
|
|
|
1,311,429
|
|
|
—
|
|
|
1,311,429
|
Effect of deemed dividend
|
|
2,554
|
|
|
—
|
|
|
66,182
|
|
|
—
|
Increase in valuation allowance
|
|
716,442
|
|
|
933,000
|
|
|
2,367,633
|
|
|
933,000
|
Other
|
|
(1,025)
|
|
|
265,618
|
|
|
(23,887)
|
|
|
388,191
|
Income tax (benefit) expense
|
$
|
(458)
|
|
$
|
1,206,131
|
|
$
|
117,207
|
|
$
|
(3,342,339)
|
|
Significant Components Of Deferred Tax Assets And Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
September 30,
|
|
2019
|
|
2018
|
Deferred tax assets:
|
|
|
|
|
|
Federal net operating loss carryforwards
|
$
|
8,527,304
|
|
$
|
6,973,047
|
State net operating loss carryforwards
|
|
2,579,909
|
|
|
2,195,865
|
Foreign net operating loss carryforwards – U.K.
|
|
10,626,155
|
|
|
10,595,518
|
Foreign capital allowance – U.K.
|
|
102,098
|
|
|
102,098
|
U.K. bad debts
|
|
1,700
|
|
|
1,700
|
Restricted stock – U.K.
|
|
17,586
|
|
|
17,586
|
U.S. deferred rent
|
|
52,257
|
|
|
22,902
|
Share-based compensation
|
|
843,466
|
|
|
622,442
|
Other, net – U.S.
|
|
159,497
|
|
|
91,419
|
Other, net – Malaysia
|
|
33,896
|
|
|
33,843
|
Gross deferred tax assets
|
|
22,943,868
|
|
|
20,656,420
|
Valuation allowance for deferred tax assets
|
|
(9,998,711)
|
|
|
(7,631,078)
|
Net deferred tax assets
|
|
12,945,157
|
|
|
13,025,342
|
Deferred tax liabilities:
|
|
|
|
|
|
In process research and development
|
|
(4,675,860)
|
|
|
(4,675,860)
|
Developed technology
|
|
(502,987)
|
|
|
(549,318)
|
Covenant not-to-compete
|
|
(80,405)
|
|
|
(94,321)
|
Other
|
|
(7,318)
|
|
|
(6,843)
|
Net deferred tax liabilities
|
|
(5,266,570)
|
|
|
(5,326,342)
|
Net deferred tax asset
|
$
|
7,678,587
|
|
$
|
7,699,000
|
|
Schedule Of Deferred Tax Amounts Classified In Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
September 30,
|
|
2019
|
|
2018
|
|
|
|
|
|
|
Deferred tax asset – U.K.
|
$
|
8,540,552
|
|
$
|
8,509,915
|
Deferred tax asset – Malaysia
|
|
33,896
|
|
|
33,843
|
Total deferred tax asset
|
$
|
8,574,448
|
|
$
|
8,543,758
|
|
|
|
|
|
|
Deferred tax liability – U.S.
|
|
(895,861)
|
|
|
(844,758)
|
Total deferred tax liability
|
$
|
(895,861)
|
|
$
|
(844,758)
|
|